SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010898
Filing Date
2017-05-15
Accepted
2017-05-15 08:46:46
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20170331.htm 10-Q 1425481
2 EX-31.1 abio-ex311_6.htm EX-31.1 8575
3 EX-31.2 abio-ex312_7.htm EX-31.2 8533
4 EX-32.1 abio-ex321_8.htm EX-32.1 11234
  Complete submission text file 0001564590-17-010898.txt   4811767

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20170331.xml EX-101.INS 1014011
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20170331.xsd EX-101.SCH 37168
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20170331_cal.xml EX-101.CAL 33208
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20170331_def.xml EX-101.DEF 94584
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20170331_lab.xml EX-101.LAB 291278
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20170331_pre.xml EX-101.PRE 211140
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 17841366
SIC: 2835 In Vitro & In Vivo Diagnostic Substances